ACTA is a national peak body focussed on delivering better health outcomes though best evidence. We represent clinical trial networks, clinical quality registries and clinical trial coordinating centres. ACTAs members play a fundamental role in identifying ways in which clinical care can be improved through comparative effectiveness studies and through the collection of information on how clinical services have been delivered as patients move through their clinical care journey. Together, these two arms of inquiry provide evidence that supports the Australian Government to optimise health service delivery.
According to an analysis published in the Journal of Clinical Epidemiology by Howick et.al, it is suggested that only 1 in 10 outcomes for health care interventions are supported by high-quality evidence. Whilst this is surprisingly low, there is clearly an opportunity to improve clinical care through provision of insights and importantly, through carefully managing the implementation of these findings.
Our advocacy activities naturally focus on promoting the role of our members who provide a critical function to support the future wellbeing of all Australians. We aim to inform governments, healthcare policymakers and sector colleagues on issues that impact the conduct of investigator-initiated clinical trials and clinical quality registries.
Strong engagement and partnerships between policymakers, clinical researchers and health data custodians significantly improves our capacity to generate high-quality evidence for new and existing therapies. We are committed to working with our members to create, strengthen, and expand collaboration opportunities, and promote the value proposition of clinical trials and clinical quality registries.
Our focus
Our advocacy efforts focus on:
- Advocating for reforms to strengthen the investigator-initiated clinical trials and clinical quality registry sectors
- Supporting the embedding of a learning healthcare system model
- Working with our industry partners to develop a globally competitive clinical trials environment
Consultations
ACTA is committed to representing its members, one way we do this is by participating in consultations.
Submission examples
Consultation | Consultation call from | Submission date | ACTA's submission |
Review of the 2016 Statement on Consumer and Community Involvement in Health and Medical Research | NHMRC | 15 June 2024 | View |
Improving alignment and coordination between the Medical Research Future Fund and Medical Research Endowment Account | Department of Health and Aged Care | 14 July 2023 | View |
Framework for Australian Clinical Quality Registries Consultation | Australian Commission on Safety and Quality in Health Care (ACSQHC) | 31 March 2023 | View |
Healthcare Identifiers Framework Project Consultation | Department of Health and Aged Care | 28 February 2023 | View |
If you would like to be involved in a submission, or find out more information about ACTA’s advocacy and consultation activities, please contact us.
Latest Resources
-
-
Official Opening of the 2020 ACTA Summit: Minister’s Address
-
ACTA submission: Parliamentary Inquiry into approval processes for new drugs and novel medical technologies in Australia
-
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia
-
ACTA Trial of the Year Award 2020 guidelines and nomination forms
-
ACTA Year in Review: Financial Year 2018-2019
-
Report on the activities and achievements of clinical trials networks in Australia 2004 – 2014
-
Submission to MRFF Consultation
-
Submission to Medical Research Future Fund Priority Consultation
-
Medical Research Future Fund – clinical trial funding set to deliver significant benefits to Australian patients and the economy
-
ACTA Advisory Council minutes July 2017
-
Economic evaluation of investigator-initiated clinical trials conducted by networks
-
Opportunities for linking evidence development to reimbursement in Australia
-
Clinical Quality Registries: A national approach
-
How can clinical trials networks drive better translation of evidence into better quality care?
-
The Global Perspective: Measuring the impact of Australian-led trials & registries internationally
-
ACTA Summit 2016 – Opening address
-
ACTA Submission to the NHMRC Public Consultation on revisions to sections 3 & 5 of the National Statement
-
ACTA Summit 2016 – Dr Neil Soderlund
-
Medical Research Future Fund set to put high quality evidence at the heart of healthcare – historic moment for all Australians
-
ACTA Submission to the NHMRC Structural Review
-
ACTA Submission on the MRFF Strategy & Priorities
-
ACTA Submission on the National Safety and Quality Health Service Standards Version 2: Consultation Draft
-
ACTA Submission to the Medicare Benefits Schedule Review Taskforce
-
ACTA Submission to the Community Affairs Legislation Committee on the Medical Research Future Fund Bill 2015
-
ACTA submission on safety monitoring & reporting of clincial trials in Australia
-
ACTA Submission to The Independent Hospital Pricing Authority (IHPA) Teaching, Training and Research Costing Study
-
ACTA Submission on draft Principles for accessing and using publicly funded data for health research
-
WA Health joins national alliance for better evidence in healthcare
-
ACTA submission on revised table of standard costs for clinical trials
-
Report on the ACTA 2014 National Summit of Clinical Trials Networks
-
ACTA submission to the ACSQHC on variation in healthcare
-
ACTA Submission to the Select Committee on Health
-
ACTA Submission to the NHMRC Statement on Consumer & Community Involvement in Health & Medical Research: Public Consultation
-
ACTA Submission to Senate Inquiry into Australia’s Innovation System
-
Australian clinical trials networks shaping modern medicine: Local doctors recognised among the world’s most influential researchers of our time
Latest News
-
ACTA welcomes $1.89b investment in Australian health and medical research including support for a National One Stop Shop
-
2023 ACTA International Clinical Trials Symposium
-
Media Release: PHRP Excellence Awards – Highly Commended In Practice paper
-
New MRFF Strategy and Priorities released
-
ACTA welcomes inquiry findings into the approval processes for new drugs and novel medical technologies in Australia
-
Research Australia web consultation
-
ACSQHC – National One-Stop-Shop Survey
-
Clinical Trials – Phase 2 Advisory Committee Communique – Meeting 6, 1 October 2021
-
National Clinical Trials Governance Framework Pilot: Update
-
National One-Stop-Shop
-
White Coats Foundation: Power of One Campaign
-
Parliamentary Inquiry into approval processes for new drugs and novel medical technologies in Australia
-
ARDC HeSANDA Australian Data Partnerships Program: Open Call
-
Continuity of Care Collaboration (CCC) Forum – Rural and Remote Health
-
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia
-
ACTA STInG: signatories to open letters addressing statistical analysis and data integrity in COVID-19 publications
-
Australian Clinical Trials Alliance celebrating and honouring clinical trials on International Clinical Trials Day
-
National Medical Stockpile: Supply of experimental medicines to support clinical trials
-
Tweetchats with PRAXIS and ACTA
-
ACTA statement on COVID-19
-
Nominations extended for ACTA Trial of the Year Awards
-
ACTA—a year in review, 2018-2019 financial year
-
ACTA announces new Board: productive diversity
Latest Events
-
Sector consultations – online discussion with ACTA
-
Clinical Trials 2021: National Tribute and Award Ceremony
-
Clinical Trials 2020: National Tribute and Award Ceremony
-
ACTA Advisory Council Meeting
-
Continuity of Care Collaboration (CCC) Forum – Rural and Remote Health
-
ARDC HeSANDA Australian Data Partnerships Program: Open Call